Sicagen India Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Attractively valued vs sector (P/E 11.3x vs industry 43.8x)
- ✓Trading below book value (P/B 0.4x)
- ✓Low debt relative to equity (D/E 0.3x)
- ✓Regular dividends — yield 1.9%
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| ADANIPORTS Adani Ports and Special Economic Zone Limited | ₹1,818 | ₹4.2L Cr | 32.7 | 4.37 | 16.4 | 14.1 | 0.85 |
| INDIGO InterGlobe Aviation Limited | ₹5,115 | ₹2.0L Cr | 37.4 | 28.42 | -12.2 | 7.12 | 8.67 |
| GMRAIRPORT GMR AIRPORTS LIMITED | ₹110 | ₹1.2L Cr | 561 | -46.7 | — | 11.6 | -15.17 |
| JSWINFRA JSW Infrastructure Limited | ₹345 -1.12% | ₹80K Cr | 50.2 | 6.65 | 15.4 | 13.7 | 0.52 |
| CONCOR Container Corporation of India Limited | ₹481 | ₹37K Cr | 29.9 | 2.83 | 9.81 | 12.4 | 0.07 |
| DELHIVERY Delhivery Limited | ₹466 | ₹37K Cr | 206 | 3.61 | 1.87 | 2.82 | 0.17 |
| REDINGTON Redington Limited | ₹270 +0.17% | ₹22K Cr | 13.5 | 1.84 | 16.9 | 18.4 | 0.27 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SICAGEN · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 55.46% | 55.46% | 55.46% | 60.39% | 60.39% | 60.39% |
| FII | 7.34% | 7.34% | 7.34% | 2.42% | 2.42% | 2.42% |
| DII | 0.60% | 0.60% | 0.60% | 0.60% | 0.58% | 0.58% |
| Public | 36.60% | 36.58% | 36.59% | 36.58% | 36.61% | 36.61% |
Latest News
All news →Sicagen India reports Q4 earnings and revenue
*Sicagen India reports Q4 earnings and revenue.* The company posted **₹X crore** revenue and **₹Y crore** profit, showing **Z%** YoY growth. Results reflect strong performance in its key pharmaceutical segments. Market reaction expected on guidance and margins. 📊 *STOCKS:* SICAGEN | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Earnings
Sicagen India trading at forward P/E of 25.4x
*Sicagen India trading at forward P/E of 25.4x.* This valuation reflects **25.4x** forward earnings, suggesting premium pricing versus sector peers. Elevated P/E may indicate growth expectations or overvaluation depending on future performance. Traders should monitor upcoming earnings for justification of current multiples. 📊 *STOCKS:* SICAGEN | 🏢 *SECTOR:* Pharma | #LOWIMPACT #P/Eratio